NEW YORK--(BUSINESS WIRE)--PulsePoint, the leading global authority in programmatic health technology, and Hu-manity.co, the company behind the #My31 movement to advance personal ownership of health data, today announced a partnership to enable how digital identity is utilized across the internet.
“The result of this partnership will have tremendous implications for a number of healthcare use cases, from clinical trial recruitment to encouraging adherence.”
The partnership between the companies has two immediate points of impact. First, it shows a real-world way for people and brands to partner around healthcare advertising data. And second, it opens up Hu-manity.co’s #My31 movement to enter the programmatic health technology space, empowering people to claim their digital identity as their property and to be compensated.
With the most intelligent health-centered view of the customer, PulsePoint has pioneered radical health personalization™. The company’s data technology, Genome by PulsePoint™, accelerates the discovery and activation of patients and providers across its programmatic health platform. By combining consented health and other real-world evidence, there is an opportunity to surface insights leading to faster diagnosis, improving treatments and supporting better health outcomes.
“This notion of fair trade data is very powerful because people will gain control of how their individual digital identities are used,” says Richie Etwaru, founder and CEO of Hu-manity.co. “The result of this partnership will have tremendous implications for a number of healthcare use cases, from clinical trial recruitment to encouraging adherence.”
Once enough users have chosen to opt-in to Hu-manity.co’s #My31 app (Android and iPhone), individuals will be able to decide who can market to them as well as what type of products or services they want to learn more about. Whenever a person’s data is used, that person would receive fair market compensation for the value of that data.
“We believe we will be on the right side of big data history as we explore ways to incorporate the Hu-manity ID into the 110 billion daily opportunities PulsePoint executes between advertisers and publishers. This will bring a new level of trust and transparency to advertisers and users,” said Sloan Gaon, CEO of PulsePoint.
PulsePoint is the leading global authority in programmatic health technology. With the most intelligent health-centered view of the customer, PulsePoint has pioneered radical health personalization™, accelerating the discovery and activation of patients and providers for real world outcomes, while helping publishers increase ad revenue through actionable insights. PulsePoint's core competencies include proprietary data capabilities, natural language processing, and reach across digital devices. On the strength of these capabilities, PulsePoint manages a successful programmatic exchange and content marketing distribution platform for all industry verticals. Investors in the company include Draper Fisher Jurvetson (DFJ), Gotham Ventures, New Atlantic Ventures (NAV), Patricia Industries, Updata Partners and VantagePoint Capital Partners.
Hu-manity.co is the world’s first and only organization developing human rights and corollary sovereign laws in a decentralized manner on blockchains. The company has headquarters in New Jersey, USA and operates in multiple countries. The leadership team includes over two dozen senior executives from Fortune 500 companies, academic scholars, and senior policy advisors from North America, Europe, Australia and Africa. The vision of Hu-manity.co is a world where the next generation of human rights and policies emerge from a balance of centralized power and decentralized technologically empowered communities. The mission is to create the 31st Human Right in a decentralized manner as an example for other organizations and visionaries to follow.
31st Human Right:
“Everyone has the right to legal ownership of their inherent human data as property.”
For more information please visit https://hu-manity.co.
By submitting your name and email and pressing submit, you are consenting to receive email marketing materials from PulsePoint.